Chemical Stabilization and Transformation of Schiff Base Scaffold: A Path toward Superior Platinum-Based Anti-Cancer Stem Cell Drugs
Journal of Medicinal Chemistry · 10.09.2026 · 69 (17) · 20943-20966
DOI: 10.1021/acs.jmedchem.6c01871 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 14.08.2026. Verfasst von Cynthia Sinaí Novoa-Ramirez und 5 weiteren Autor:innen. Beteiligte Einrichtung: Universidad Autónoma de Madrid (UAM), Department of Inorganic Chemistry, Madrid28049, Spain. Hauptthemen laut MEDLINE: Neoplastic Stem Cells, Antineoplastic Agents, Organoplatinum Compounds. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Ciencia, Innovaci?n y Universidades, Secretar?a de Educaci?n Superior, Ciencia, Tecnolog?a e Innovaci?n.
Abstract (Originalsprache)
The clinical application of platinum-based anticancer agents is limited by poor aqueous stability, low solubility, and dose-limiting toxicities. Here, we report two Pt(II) complexes based on a Schiff base ligand and its reduced imine derivative, designed to overcome these limitations. We show that ligand stabilization through imine reduction markedly improves solution stability, which emerges as an important contributor to interaction, cellular responses, and antiproliferative activity. ICP-MS analysis demonstrated efficient intracellular platinum accumulation with preferential nuclear localization. The lead compound also displayed potent activity against gastric cancer stem-like cells by impairing self-renewal and pluripotency. Transcriptomic and functional analyses associated this effect with suppression of stemness and epithelial-to-mesenchymal transition-related transcriptional programs, reduced OCT3/4 expression, and activation of DNA damage, apoptosis, and oxidative stress pathways. These findings identify a promising Pt(II) scaffold for targeting cancer stem cell-associated phenotypes and establish ligand stabilization as an effective strategy for developing next-generation platinum anticancer agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Universidad Autónoma de Madrid (UAM), Department of Inorganic Chemistry, Madrid28049, Spain.
- Department of Biochemistry, School of Medicine, UAM, Madrid28029, Spain.
- Instituto de Investigaciones Biomédicas "Sols-Morreale" IIBM-CSIC-UAM, Madrid28029, Spain.
- BIOPAC-IRYCIS, Madrid28034, Spain.
- Institute of Advanced Chemical Sciences (IAdChem), UAM, Madrid28039, Spain.
- Centro de Investigación Biomédica En Red de Enfermedades Raras (CIBERER) ISCIII, Madrid28029, Spain.
ORCID-Profile: Leticia Cubo Martín, Adoración Gómez Quiroga
Förderung
- Ministerio de Ciencia, Innovaci?n y Universidades
- Secretar?a de Educaci?n Superior, Ciencia, Tecnolog?a e Innovaci?n
Zitieren
APA
Novoa-Ramirez, C. S., Melones Herrero, J., Gutierrez, S. P., Cubo Martín, L., Quiroga, A. G., & Sanchez Pérez, I. (2026). Chemical Stabilization and Transformation of Schiff Base Scaffold: A Path toward Superior Platinum-Based Anti-Cancer Stem Cell Drugs. Journal of Medicinal Chemistry, 69(17), 20943-20966. https://doi.org/10.1021/acs.jmedchem.6c01871
Vancouver
Novoa-Ramirez CS, Melones Herrero J, Gutierrez SP, Cubo Martín L, Quiroga AG, Sanchez Pérez I. Chemical Stabilization and Transformation of Schiff Base Scaffold: A Path toward Superior Platinum-Based Anti-Cancer Stem Cell Drugs. Journal of Medicinal Chemistry. 2026;69(17):20943-20966. doi:10.1021/acs.jmedchem.6c01871
BibTeX
@article{NovoaRamirez2026,
author = {Novoa-Ramirez, Cynthia Sinaí and Melones Herrero, Jorge and Gutierrez, Susana Priego and Cubo Martín, Leticia and Quiroga, Adoración Gómez and Sanchez Pérez, Isabel},
title = {Chemical Stabilization and Transformation of Schiff Base Scaffold: A Path toward Superior Platinum-Based Anti-Cancer Stem Cell Drugs},
journal = {Journal of Medicinal Chemistry},
year = {2026},
volume = {69},
number = {17},
pages = {20943--20966},
doi = {10.1021/acs.jmedchem.6c01871}
}
EUVIMED